60 related articles for article (PubMed ID: 36286264)
21. An ultra performance liquid chromatography method for transthyretin variants screening and heart failure assisting diagnosis.
Wang S; Guan L; Sun Y; Cui L; Guo S; Wang M; Liu Y; Cui X; Zhao F; Zhang Y; Cao Y
Clin Chim Acta; 2024 Jan; 553():117709. PubMed ID: 38103852
[TBL] [Abstract][Full Text] [Related]
22. Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis.
Lau KHV; Prokaeva T; Zheng L; Doros G; Kaku MC; Spencer B; Berk J; Sanchorawala V
Amyloid; 2024 Jun; 31(2):150-152. PubMed ID: 38073425
[No Abstract] [Full Text] [Related]
23. Non-Cardiac Amyloidosis Findings Are Not Increased in African American Carriers of
Kaniper S; Lynch D; Owens SM; Ibric L; Vabishchevich Y; Nyantakyi N; Chun F; Sam L; Fabrizio C; Hamad E; Gerhard GS
J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38541013
[TBL] [Abstract][Full Text] [Related]
24. Race, Genotype, and Prognosis in Black Patients With Transthyretin Cardiac Amyloidosis.
Khedraki R; Saef J; Martens P; Martyn T; Sul L; Hachamovitch R; Ives L; Estep JD; Tang WHW; Hanna M
Am J Cardiol; 2024 Apr; 216():66-76. PubMed ID: 38278432
[TBL] [Abstract][Full Text] [Related]
25. Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy.
Mazzarotto F; Argirò A; Zampieri M; Magri C; Giotti I; Boschi B; Frusconi S; Gennarelli M; Buxbaum J; Polimanti R; Olivotto I; Perfetto F; Cappelli F
Eur J Hum Genet; 2023 May; 31(5):541-547. PubMed ID: 36380086
[TBL] [Abstract][Full Text] [Related]
26. Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca.
Cisneros-Barroso E; Gorram F; Ribot-Sansó MA; Alarcon F; Nuel G; González-Moreno J; Rodríguez A; Hernandez-Rodriguez J; Amengual-Cladera E; Martínez-López I; Ripoll-Vera T; Losada-López I; Heine-Suñer D; Plante-Bordeneuve V
Orphanet J Rare Dis; 2023 Aug; 18(1):255. PubMed ID: 37653545
[TBL] [Abstract][Full Text] [Related]
27. Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
McColgan P; Viegas S; Gandhi S; Bull K; Tudor R; Sheikh F; Pinney J; Fontana M; Rowczenio D; Gillmore JD; Gilbertson JA; Whelan CJ; Shah S; Jaunmuktane Z; Holton JL; Schott JM; Werring DJ; Hawkins PN; Reilly MM
J Neurol; 2015 Jan; 262(1):228-34. PubMed ID: 25488473
[TBL] [Abstract][Full Text] [Related]
28. Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US.
Selvaraj S; Claggett BL; Quarta CC; Yu B; Inciardi RM; Buxbaum JN; Mosley TH; Shah AM; Dorbala S; Falk RH; Solomon SD
JAMA Cardiol; 2023 Aug; 8(8):784-788. PubMed ID: 37212191
[TBL] [Abstract][Full Text] [Related]
29. Transbronchial cryobiopsy proven amyloid diffuse cystic lung disease complicating a transthyretin mutated (ATTRm) amyloidosis: a case report.
Gaultier S; Puscas T; Pastre J; Gibault L; Arlet JB; Cauquil C; Michon A
Ther Adv Respir Dis; 2023; 17():17534666231178690. PubMed ID: 37329289
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis.
He X; Wang M; Sun J; Yu Z; Hu X; Liu Y; Lin X
Cardiology; 2024 Mar; ():. PubMed ID: 38437799
[TBL] [Abstract][Full Text] [Related]
31. Erratum to 'Disentangling Knots of Misfolded Proteins: Do We Really Know the Prognostic Implications of the Pathogenic V122I TTR Variant?' [The American Journal of Cardiology 221 (2024) 131-132].
Jawaid A; Wees I; Grodin JL
Am J Cardiol; 2024 Jun; ():. PubMed ID: 38885934
[No Abstract] [Full Text] [Related]
32. Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: Neurological and cardiological features.
Gentile L; Di Bella G; Minutoli F; Cucinotta F; Obici L; Mussinelli R; Arimatea I; Russo M; Toscano A; Vita G; Mazzeo A
J Peripher Nerv Syst; 2020 Sep; 25(3):273-278. PubMed ID: 32395865
[TBL] [Abstract][Full Text] [Related]
33. Transthyretin: Its function and amyloid formation.
Ueda M
Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
[TBL] [Abstract][Full Text] [Related]
34. Hereditary transthyretin amyloidosis overview.
Manganelli F; Fabrizi GM; Luigetti M; Mandich P; Mazzeo A; Pareyson D
Neurol Sci; 2022 Dec; 43(Suppl 2):595-604. PubMed ID: 33188616
[TBL] [Abstract][Full Text] [Related]
35. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis.
Prokaeva T; Klimtchuk ES; Feschenko P; Spencer B; Cui H; Burks EJ; Aslebagh R; Muneeruddin K; Shaffer SA; Varghese E; Berk JL; Connors LH
Amyloid; 2023 Jun; 30(2):141-152. PubMed ID: 36286264
[TBL] [Abstract][Full Text] [Related]
36. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
[TBL] [Abstract][Full Text] [Related]
37. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
